CPhI China 2013 Increases Customer Content Services and Expands Thanks to a Double Digit Pharma Industry Growth Rate and a Burgeoning Generics Market

Amsterdam (ots/PRNewswire) -

Co-located events P-MEC/ICSE/BioPh/InnoPack/LABWorld are helping
to build improved partnerships and drive GMP standards across the
region

CPhI announces that CPhI China [http://www.cphi-china.com ], an
event organised by UBM Live and UBM Sinoexpo, is returning to the
Shanghai New International Expo Center (25-27 June 2013, Shanghai)
for the 13th consecutive year - with an increased scale, more
informative exhibition and regional networking opportunities and a
greater range of content services than it has ever offered before.
With a view to enhancing the customer experience and ROI value, CPhI
China has added mobile applications, high value conferences, a live
laboratory showcase and re-launched the show daily. Furthermore, the
2013 event has a strong focus on R&D with LABWorld, BioPharma and
ICSE all contained in one hall. China has increasingly become a focal
point of the pharmaceutical industry and is now the 3rd largest
market in the world. Fuelled by increasing healthcare demands within
its own borders as well as by international companies seeking
manufacturing facilities, China's hunger for foreign partnerships and
pharmaceutical ingredients presents a great opportunity for
international and domestic suppliers and buyers.

CPhI China is back this year as the main event for the
pharmaceutical ingredients industry in the fast growing Chinese
market. We expect to welcome 2,300 exhibitors, and 30,000 visitors
from more than 100 countries, CPhI China 2013 is a unique one-stop
platform to meet current partners, build new relationships, evaluate
pharmaceutical products and learn about the latest industry trends.

Co-located events re-confirmed for the 2013 edition will be P-MEC
China, which covers machinery and equipment; ICSE China, for
companies providing outsourcing services in custom synthesis and
clinical trials; BioPh China, a dedicated platform for
biopharmaceuticals; and InnoPack, focussed on bringing global
packaging solutions to the Chinese pharma companies. Additionally,
following huge demand in 2012, this year will also see a significant
expansion of co-located event, LABWorld China - which will focus on
innovation and new developments, providing a forum for increased
education and networking for businesses in the laboratory, analytical
and biotech equipment sector.

The number of exhibitors already registered has seen a tremendous
upsurge thanks to increased Chinese manufacturing opportunities and
huge growth in China's generics sector. This rapid development,
coupled with the evolving regulatory landscape is attracting both
domestic and international investors to the Chinese market.

CPhI China 2013 brings great expectations and is a must attend
event for anyone interested in breaking into China's pharmaceuticals
market and establishing Chinese partners.

"In 2012, the size of the Chinese pharmaceutical market reached
926.1 billion RMB, and is expected to expand at an annual rate of 12%
from 2013 to 2020," announced Nik Rudge, Managing Director at UBM
Live. "Today, leading Chinese CROs and pharmaceutical companies are
able to offer high quality, cost-effective services on a global scale
with growth rates forecast to far outpace the rest of the industry.
The increasing ability of Chinese companies to meet international
standards in drug quality and safety, coupled with strong growth in
the local market, makes this is a must attend event for any
pharmaceutical company in 2013 - whether Chinese, regional or
international in focus."

Attendance to the events is free for qualified pharmaceutical
professionals at http://www.cphi-china.com

Event information:
CPhI China
25-27 June 2013
The Shanghai New International Expo Center
http://www.cphi-china.com

Notes for Editors

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. The flagship event, CPhI Worldwide is held in Europe, with
additional events in China, India, Japan, Southeast Asia, Russia and
South America co-located with ICSE for contract services, P-MEC for
equipment, InnoPack for packaging and BioPh for biopharma. CPhI
provides an online buyer & supplier directory at CPhI-Online.com and
hosts a global community with news and analysis at
PharmaEvolution.com, produced by UBM Live and partners.

For more information visit: http://www.cphi.com

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

For media enquiries, please contact:

Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6745/6740
E: a.heeley@defacto.com t.jervis@defacto.com

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de